|
Recombinant Human Procollagen I N-Terminal Propeptide (PINP) |
|
Description |
Recombinant Human Procollagen I N-Terminal Propeptide (PINP),expressed in Escherichia coli (E. coli) and purified by standard chromatographic techniques. |
|
Formulation Buffer |
20mM Tris, 150mM NaCl, pH8.0, containing 0.01% skl, 5%Trehalose. |
|
Purity |
> 95% pure as determined by Silver stained SDS-PAGE analysis. Molecular Weight: ~40KDa |
|
Storage |
Shipped at 2-8°C. Aliqote and Storet at-80C; Avoid repeated freeze/thaw cycles. |
|
Background |
Procollagen I N- Terminal Proprptide (PINP) is an amino terminal propertied which correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and postmenopausal nonmetastatic breast cancer patients. |
